Quattro Financial Advisors LLC Biomarin Pharmaceutical Inc Transaction History

Quattro Financial Advisors LLC

  • $371 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023
SELL
$87.74 - $117.27 $438,700 - $586,350
-5,000 Reduced 50.0%
5,000 $486,000
Q2 2022

Aug 01, 2022
SELL
$71.48 - $86.85 $142,960 - $173,700
-2,000 Reduced 16.67%
10,000 $829,000
Q1 2021

Apr 22, 2021
BUY
$74.73 - $90.69 $896,760 - $1.09 Million
12,000 New
12,000 $958,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Quattro Financial Advisors LLC Portfolio

Follow Quattro Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quattro Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quattro Financial Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email